South Africa’s Deputy President Paul Mashatile Calls for Global Partnerships to Accelerate Sustainable Regional Vaccine Manufacturing in Africa

Cape Town, South Africa – Deputy President Paul Mashatile of South Africa has called for global partnerships to accelerate sustainable regional vaccine manufacturing in Africa.

Mashatile made the call in his opening address at the 24th Annual General Meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) in Cape Town on Tuesday, September 19, 2023.

The DCVMN is an alliance of over 40 vaccine manufacturers from 15 developing countries, and it produces the most vaccines globally.

Mashatile said that the COVID-19 pandemic has highlighted the importance of vaccine manufacturing in developing countries, as many countries in the Global South struggled to access vaccines during the pandemic.

“We cannot remain reliant on external sources for vaccines and pandemic readiness,” he said.

Mashatile urged the DCVMN members to collaborate with African governments and the global community to transfer technology, knowledge, and expertise to Africa.

“By doing so, we can create a thriving pharmaceutical industry that not only meets our domestic needs but also contributes to the global fight against infectious diseases,” he said.

Mashatile also called for investment in the development of Africa’s pharmaceutical industry and healthcare systems.

“We must invest in building a resilient Africa, one that is prepared to face future pandemics,” he said.

Mashatile’s call for global partnerships to accelerate sustainable regional vaccine manufacturing in Africa is timely and important. The COVID-19 pandemic has shown the world the importance of vaccine manufacturing, and it is clear that Africa needs to develop its own vaccine manufacturing capacity to ensure that it is not left behind in the next pandemic.

Global partnerships can play a vital role in helping Africa to develop its vaccine manufacturing capacity. By transferring technology, knowledge, and expertise to Africa, developed countries can help Africa to build a thriving pharmaceutical industry.

The DCVMN is well-positioned to play a leading role in global partnerships to accelerate sustainable regional vaccine manufacturing in Africa. The DCVMN has a wealth of experience and expertise in vaccine manufacturing, and it is committed to working with African governments and the global community to improve access to vaccines for all people.